Applying κ-sample tests to conditional probabilities for competing risks in a clinical trial

Biometrics

Volumn 54, Issue 4, 1998, Pages 1662-1672

  Lunn, Mary ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Competing risks; Conditional probability; Stratified test; sample test

Indexed keywords

CLINICAL TRIAL; COMPETING RISKS; CONDITIONAL PROBABILITIES; CUMULATIVE INCIDENCE; INCIDENCE FUNCTION; PROBABILITY OF FAILURE; PROGNOSTIC FACTORS; RISK TYPES; STRATIFIED TEST; Κ-SAMPLE TEST;

STATISTICAL TESTS;

ESTROGEN RECEPTOR; PROGESTERONE; PROGESTERONE RECEPTOR; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; MEDROXYPROGESTERONE ACETATE; TAMOXIFEN;

DATA ANALYSIS; HORMONE DETERMINATION; HORMONE RELEASE; INCIDENCE; PROBABILITY; PROGNOSIS; RECEPTOR BINDING; REVIEW; ARTICLE; BIOMETRY; BREAST TUMOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FEMALE; HUMAN; METABOLISM; METHODOLOGY; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RISK FACTOR; STATISTICS; TREATMENT FAILURE;

ANTINEOPLASTIC AGENTS, HORMONAL; BIOMETRY; BREAST NEOPLASMS; CLINICAL TRIALS; FEMALE; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; PROBABILITY; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; RECEPTORS, ESTROGEN; RECURRENCE; RISK FACTORS; TAMOXIFEN; TREATMENT FAILURE;

EID: 0032216740     PISSN: 0006341X     EISSN: None     Source Type: Journal    
DOI: 10.2307/2533691     Document Type: Review

References (15)

1. Andersen, P. K., Borgan, O., Gill, R. D., and Keiding, N. (1993). Statistical Models Based on Counting Processes. New York: Springer-Verlag.
2. Byrne, M. J., Gebski, V., Forbes, J., Tattersall, M., Simes, J., Coates, A., Dewar, J., Lunn, M., Flower, C., Gill G., and Stewart, J. (1997). Medroxyprogesterone acetate (MPA) addition or substitution for tamoxifen (TAM) in advanced tamoxifen resistant breast cancer. A phase III randomised trial. Journal of Clinical Oncology 15, 3141-3148.
3. Caplan, R. J., Pajak, T. F., and Cox, J. D. (1994). Analysis of the probability and risk of cause-specific failure. International Journal of Radiation Oncology, Biology, Physics 29, 1183-1186.
4. Fleming, T. R. and Harrington, D. P. (1991). Counting Processes and Survival Analysis. New York: Wiley.
5. Gaynor, J. J., Feuer, E. J., Tan, C. C., Wu, D. H., Little, C. R., Strauss, D. J., Bayard, D. C., and Brennan, M. F. (1993). On the use of cause-specific failure and conditional failure probabilities: Examples from clinical oncology data. Journal of the American Statistical Association 88, 400-409.
6. Gelman, R., Gelber, R., Henderson, I. C., Coleman, C. N., and Harris, J. R. (1990). Improved methodology for analyzing local and distant recurrence. Journal of Clinical Oncology 8, 548-555.
7. Gray, R. J. (1988). A class of κ-sample tests for comparing the cumulative incidence of a competing risk. Annals of Statistics 16, 1141-1154.
8. Kalbfleisch, J. D. and Prentice, R. L. (1980). The Statistical Analysis of Failure Time Data. New York: Wiley.
9. Kimball, A. W. (1958). Disease incidence estimation in populations subject to multiple causes of death. Bulletin of the International Statistical Institute 36, 193-204.
10. Lunn, M. and McNeil, D. R. (1995). Applying Cox regression to competing risks. Biometrics 51, 524-532.
11. Moeschberger, M. L. and Klein, J. P. (1995). Statistical methods for dependent competing risks. Lifetime Data Analysis 1, 195-204.
12. Pepe, M. S. (1991). Inference for events with dependent risks in multiple endpoint studies. Journal of the American Statistical Association 86, 770-778.
13. Pepe, M. S. and Fleming, T. R. (1989). Weighted Kaplan-Meier statistics-A class of distance tests for censored survival data. Biometrics 45, 497-507.
14. Pepe, M. S. and Mori, M. (1993). Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? Statistics in Medicine 12, 737-751.
15. Wei, L. J., Lin, D. Y., and Weissfeld, L. (1989). Regression analysis of multivariate incomplete failure time data by modelling marginal distributions. Journal of the American Statistical Association 84, 1065-1073.